Drug development entails risk. Clinical trials are elaborate and expensive experiments, and unfortunately sometimes promising hypotheses prove false. This can be frustrating and even painful at times, but ultimately such are risks worth taking, since new and improved medicines can mean the difference between life and death for patients with serious diseases. At Roivant, we embrace taking calculated risks that have the potential to meaningfully benefit patients.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile